These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 12051095)
1. Does extended lymphadenectomy improve survival of pancreatic cancer patients? Popiela T; Kedra B; Sierzega M Acta Chir Belg; 2002 Apr; 102(2):78-82. PubMed ID: 12051095 [TBL] [Abstract][Full Text] [Related]
2. [Patients with non-advanced pancreatic cancer benefit from extended lymphadenectomy]. Popiela T; Kedra B; Sierzega M; Kubisz A Zentralbl Chir; 2002 Nov; 127(11):960-4. PubMed ID: 12476369 [TBL] [Abstract][Full Text] [Related]
3. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322 [TBL] [Abstract][Full Text] [Related]
4. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Yeo CJ; Cameron JL; Sohn TA; Coleman J; Sauter PK; Hruban RH; Pitt HA; Lillemoe KD Ann Surg; 1999 May; 229(5):613-22; discussion 622-4. PubMed ID: 10235519 [TBL] [Abstract][Full Text] [Related]
5. Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma. Staerkle RF; Vuille-Dit-Bille RN; Soll C; Troller R; Samra J; Puhan MA; Breitenstein S Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011490. PubMed ID: 33471373 [TBL] [Abstract][Full Text] [Related]
6. Survival advantage with para aortic lymphadenectomy in peri-ampullary cancer: A retrospective cohort study. Hafeez Bhatti AB; Dar FS; Sahaab E; Khan NY; Zia H; Rana A; Salih M; Shah NH Int J Surg; 2016 Jul; 31():58-62. PubMed ID: 27262530 [TBL] [Abstract][Full Text] [Related]
7. [Does the extent of lymph node dissection have an effect on morbidity and prognosis after resection of the head of the pancreas for ductal or periampullary pancreatic carcinoma?]. Böttger T; Boddin J; Küchle R; Junginger T Langenbecks Arch Chir; 1997; 382(4):209-15. PubMed ID: 9445967 [TBL] [Abstract][Full Text] [Related]
8. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection]. Ridwelski K; Meyer F; Schmidt U; Lippert H Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961 [TBL] [Abstract][Full Text] [Related]
9. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation. Tsao JI; Rossi RL; Lowell JA Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796 [TBL] [Abstract][Full Text] [Related]
10. Pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma. Kennedy EP; Yeo CJ Surg Oncol Clin N Am; 2007 Jan; 16(1):157-76. PubMed ID: 17336242 [TBL] [Abstract][Full Text] [Related]
11. Factors predicting adequate lymph node yield in patients undergoing pancreatoduodenectomy for malignancy. Sierzega M; Bobrzyński Ł; Matyja A; Kulig J World J Surg Oncol; 2016 Sep; 14(1):248. PubMed ID: 27644962 [TBL] [Abstract][Full Text] [Related]
12. Pancreaticoduodenectomy for periampullary adenocarcinoma. Andersen HB; Baden H; Brahe NE; Burcharth F J Am Coll Surg; 1994 Nov; 179(5):545-52. PubMed ID: 7952456 [TBL] [Abstract][Full Text] [Related]
13. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience. Petrou A; Soonawalla Z; Silva MA; Manzelli A; Moris D; Tabet PP; Friend P J BUON; 2016; 21(4):874-882. PubMed ID: 27685908 [TBL] [Abstract][Full Text] [Related]
14. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Pedrazzoli S; DiCarlo V; Dionigi R; Mosca F; Pederzoli P; Pasquali C; Klöppel G; Dhaene K; Michelassi F Ann Surg; 1998 Oct; 228(4):508-17. PubMed ID: 9790340 [TBL] [Abstract][Full Text] [Related]
15. [Significance of occult lymphatic tumor spread in pancreatic cancer]. Milsmann C; Füzesi L; Werner C; Becker H; Horstmann O Chirurg; 2005 Nov; 76(11):1064-72. PubMed ID: 15971035 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival. Khan AW; Dhillon AP; Hutchins R; Abraham A; Shah SR; Snooks S; Davidson BR Eur J Surg Oncol; 2002 Sep; 28(6):637-44. PubMed ID: 12359201 [TBL] [Abstract][Full Text] [Related]
17. [Perioperative staging and the Münster TNM classification in ampullary and pancreatic cancer]. Clemens M; Meyer J; Sulkowski U; Sasse W; Bünte H Langenbecks Arch Chir; 1985; 365(3):169-78. PubMed ID: 2414617 [TBL] [Abstract][Full Text] [Related]
18. [Surgical therapy of pancreatic and periampullary carcinoma in elderly patients]. Benhidjeb T; Zanow J Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():489-91. PubMed ID: 9101908 [TBL] [Abstract][Full Text] [Related]
19. Surgical experience with pancreatic and periampullary cancer. Herter FP; Cooperman AM; Ahlborn TN; Antinori C Ann Surg; 1982 Mar; 195(3):274-81. PubMed ID: 6277259 [TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of 150 cases with periampullary carcinoma]. Wu XD Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):296-9. PubMed ID: 7909747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]